Chondrocyte apoptosis

Chondrocyte apoptosis refers to the programmed cell death of chondrocytes, which are the specialized cells responsible for the synthesis and maintenance of the articular cartilage extracellular matrix (ECM) [15]. In healthy adult cartilage, the rate of chondrocyte turnover is extremely low; however, accelerated apoptosis is a hallmark of degenerative joint diseases like osteoarthritis (OA), contributing significantly to cartilage thinning and joint dysfunction [13]. The resulting hypocellularity impairs the tissue's ability to repair itself, leading to a breakdown of structural integrity [5]. While chondrocyte apoptosis is a biological process rather than a discrete molecular entity, it serves as a critical therapeutic objective for the development of disease-modifying osteoarthritis drugs (DMOADs) [1, 16]. Current research focuses on modulating upstream signaling pathways, such as inhibiting pro-apoptotic caspases or upregulating pro-survival factors like Bcl-2, to preserve the chondrocyte population and joint function [4, 8]. Interventions often target the imbalance between pro-apoptotic signals, such as nitric oxide and TNF-α, and anti-apoptotic signals to prevent matrix loss [17].

Other names

Programmed chondrocyte deathCartilage cell apoptosisChondroptosis

Inhibition of programmed cell death pathways in cartilage cells, primarily through the suppression of caspases and pro-inflammatory signaling (e.g., IL-1β, TNF-α), to preserve tissue cellularity and matrix integrity [1, 5, 13].